BL 5255

RN given refers to parent cpd; structure

Also Known As:

2-(2-n-propoxyphenyl)-5-(5-1H-tetrazolyl)pyrimidin-4(3H)-one; BL 5255, monosodium salt; BL-5255; 4(1H)-Pyrimidinone, 2-(2-propoxyphenyl)-5-(1H-tetrazol-5-yl)-

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidinones: 71
      - BL 5255: 3

Related Diseases

1.	Immediate Hypersensitivity 01/01/1983 - "BL-5255 II: effects on release and smooth muscle activity of mediators of immediate hypersensitivity reactions." 01/01/1982 - "BL-5255 exhibited potent activity in several models of antigen-induced immediate hypersensitivity reactions in rats and guinea pigs. "
2.	Hypersensitivity (Allergy) 01/01/1979 - "BL-5255, 2-(2-n-propoxyphenyl)-5-(5-1 H-tetrazolyl)pyrimidin-4 (3H)-one, effectively inhibited allergic reactions in sensitized rats or guinea pigs when administered by oral or intravenous routes as the water-soluble sodium or ethanolamine monohydrate salts. "

Related Drugs and Biologics

1.	Ethanolamine (Colamine)
2.	Sodium
3.	Salts
4.	Antigens